tiprankstipranks
Trending News
More News >
Noile-Immune Biotech Inc. (JP:4893)
:4893
Japanese Market

Noile-Immune Biotech Inc. (4893) Financial Statements

Compare
0 Followers

Noile-Immune Biotech Inc. Financial Overview

Noile-Immune Biotech Inc.'s market cap is currently ¥6.75B. The company's EPS TTM is ¥-4.36; its P/E ratio is -8.51; Noile-Immune Biotech Inc. is scheduled to report earnings on February 13, 2026, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 5.00M¥ 7.59M¥ 316.82M¥ 625.78M¥ 100.73M
Gross Profit¥ 5.00M¥ 7.39M¥ 314.56M¥ 618.71M¥ 77.83M
Operating Income¥ -797.25M¥ -1.07B¥ -775.39M¥ -106.34M¥ -767.51M
EBITDA¥ -797.25M¥ -1.07B¥ -775.39M¥ -106.34M¥ -767.51M
Net Income¥ -793.54M¥ -964.46M¥ -1.13B¥ -386.62M¥ -795.03M
Balance Sheet
Cash & Short-Term Investments¥ 3.92B¥ 4.67B¥ 5.56B¥ 4.52B¥ 4.14B
Total Assets¥ 4.01B¥ 4.80B¥ 5.78B¥ 4.64B¥ 4.27B
Total Debt¥ 0.00¥ 0.00¥ 0.00¥ 0.00¥ 0.00
Net Debt¥ -3.92B¥ -4.67B¥ -5.56B¥ -4.52B¥ -4.14B
Total Liabilities¥ 79.64M¥ 74.67M¥ 91.49M¥ 340.42M¥ 85.72M
Stockholders' Equity¥ 3.93B¥ 4.73B¥ 5.69B¥ 4.30B¥ 4.19B
Cash Flow
Free Cash Flow¥ 0.00¥ -887.81M¥ -873.08M¥ -107.18M¥ -777.14M
Operating Cash Flow¥ -752.22M¥ -887.81M¥ -873.08M¥ -107.18M¥ -777.14M
Investing Cash Flow¥ -378.00K¥ 557.00K¥ -5.32M¥ 0.00¥ -4.03M
Financing Cash Flow¥ -20.00K¥ 2.50M¥ 1.91B¥ 487.62M¥ 2.37B
Currency in JPY

Noile-Immune Biotech Inc. Earnings and Revenue History

Noile-Immune Biotech Inc. Debt to Assets

Noile-Immune Biotech Inc. Cash Flow

Noile-Immune Biotech Inc. Forecast EPS vs Actual EPS